Natco Pharma Limited

Natco Pharma Ltd is a vertically integrated and research-driven pharmaceutical company headquartered in Hyderabad, India. Established in 1981, Natco specializes in the development, manufacture, and marketing of finished dosage formulations and active pharmaceutical ingredients (APIs). The company operates across both domestic and international markets, with a significant presence in highly regulated geographies such as the US, Canada, and Europe. Natco is recognized for its strong capabilities in oncology, hepatitis C, cardiology, and niche therapeutics, focusing on complex generics, specialty pharmaceuticals, and agrochemicals.

With robust R&D infrastructure and investments, Natco has a track record of being a first-mover in the Indian generic pharmaceutical space, frequently launching generic versions of high-value drugs post-patent expiry. The company collaborates with global partners for product development, licensing, and distribution, and continues to pursue opportunities in both regulated and growth/emerging markets.